T淋巴细胞免疫缺陷的HIV阴性患者易感。
高危人群包括器官移植患者和血液系统恶性肿瘤患者。
低危或风险不确定的人群包括患者长期进行免疫抑制治疗,如使用肿瘤坏死因子-α拮抗剂。[20]Gilmartin GS, Koziel H. Pneumocystis carinii pneumonia in adult non-HIV disorders. J Intensive Care Med. 2002;17:283-301.[27]Harigai M, Koike R, Miyasaka M, et al. Pneumocystis pneumonia associated with infliximab in Japan. N Engl J Med. 2007;357:1874-1876.http://www.ncbi.nlm.nih.gov/pubmed/17978303?tool=bestpractice.com[28]Imaizumi K, Sugishita M, Usui M, et al. Pulmonary infectious complications associated with anti-TNFalpha therapy (infliximab) for rheumatoid arthritis. Intern Med. 2006;45: 685-688.http://www.ncbi.nlm.nih.gov/pubmed/16778341?tool=bestpractice.com[29]Kalyoncu U, Karadag O, Akdogan A, et al. Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab. Scand J Infect Dis. 2007;39:475-478.http://www.ncbi.nlm.nih.gov/pubmed/17464877?tool=bestpractice.com[30]Lahiff C, Khiaron OB, Nolan N, et al. Pneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis. Ir J Med Sci. 2007;176:309-311.http://www.ncbi.nlm.nih.gov/pubmed/17906888?tool=bestpractice.com[31]Mori S, Imamura S, Fiyofiji C, et al. Pneumocystis jiroveci pneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumor necrosis factor alpha neutralizing antibody. Mod Rheumatol. 2006;16:58-62.http://www.ncbi.nlm.nih.gov/pubmed/16622728?tool=bestpractice.com